NIIC and RFA

Nanoparticle-Induced Immunoresponsive Correction and Redirection of Fat Accumulation
Home
The Problem
The Solution
Prototype
Impacts
Sources
Home

As the seventh leading cause of deaths in the U.S., diabetes is a highly debilitating disease that has very few treatment options. In a combination of nanotechnology and islet transplants, NIIC presents a cure for Type I diabetes. RFA, as a cure for Type II diabetes, prevents the build up of fat in key areas such as the heart and muscles.

This website contains information on the problem of diabetes, how our technologies work to cure both types, and future developments. Thank you for visiting our website!